SANOFI SYNTHELABO SA 13D and 13G filings for Regeneron Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-17 5:10 pm Sale |
2020-06-12 | 13D | Regeneron Pharmaceuticals, Inc. REGN |
SANOFI SYNTHELABO SA | 279,766 0.300% |
-22,941,685 (-98.80%) |
Filing |
| 2020-05-29 4:15 pm Sale |
2020-05-25 | 13D | Regeneron Pharmaceuticals, Inc. REGN |
SANOFI SYNTHELABO SA | 23,221,451 21.000% |
-128,914 (-0.55%) |
Filing |